The value-based care space is slowly growing, but factors like payment and regulatory uncertainty are shaping its trajectory. Here's what to know.

The organizations plan to develop a global healthcare delivery platform to improve patient care and financial outcomes.

The partnership with top health agencies and companies like Mark Cuban's Cost Plus Drug Company aims to use AI to produce drugs at care sites.

Digital health investors are shifting their focus to a select number of companies with sustainable business models. 

Pharmacy benefit managers face new compensation restrictions and transparency rules from the sweeping reconciliation budget advancing in Congress.

Executive recruiting firms report a sharp decline in interest in diversity, equity and inclusion hiring initiatives within the healthcare sector.

Multiple artificial intelligence-related companies secured deals this week.

A group of 120 accountable care organizations say an ongoing problem with savings targets could substantially cost providers. 

Catch up on what you need to read to finish your week.